{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:44:56Z","timestamp":1791852296857,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":563,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23390250"],"award-info":[{"award-number":["23390250"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H21-G-002"],"award-info":[{"award-number":["H21-G-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H22-AIDS-I-002"],"award-info":[{"award-number":["H22-AIDS-I-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ccr.2011.12.015","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T19:03:26Z","timestamp":1326827006000},"page":"121-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":314,"title":["Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-\u03baB Pathway in Adult T Cell Leukemia and Other Cancers"],"prefix":"10.1016","volume":"21","author":[{"given":"Makoto","family":"Yamagishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariko","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanori","family":"Yamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Sato-Otsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Uchimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2011.12.015_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib3","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2008-11-189845","article-title":"Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia","volume":"113","author":"Bellon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.12.015_bib4","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1101\/gad.1241904","article-title":"The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation","volume":"18","author":"Caretti","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2011.12.015_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07399","article-title":"Oncogenic mutations of ALK kinase in neuroblastoma","volume":"455","author":"Chen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2011.12.015_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature07086","article-title":"SMAD proteins control DROSHA-mediated microRNA maturation","volume":"454","author":"Davis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2011.12.015_bib7","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2009-03-213496","article-title":"Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells","volume":"114","author":"Fiskus","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.12.015_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1593\/neo.03388","article-title":"Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells","volume":"6","author":"Hironaka","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.ccr.2011.12.015_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1535-6108(04)00084-4","article-title":"The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma","volume":"5","author":"Horie","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.12.015_bib12","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2011.12.015_bib13","doi-asserted-by":"crossref","first-page":"26243","DOI":"10.1074\/jbc.M403286200","article-title":"Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation","volume":"279","author":"Liao","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2011.12.015_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/385540a0","article-title":"MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1","volume":"385","author":"Malinin","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2011.12.015_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2100","article-title":"An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB","volume":"16","author":"Min","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2011.12.015_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-009-0267-2","article-title":"NF-kappaB and cancer: how intimate is this relationship","volume":"336","author":"Prasad","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ccr.2011.12.015_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2004.08.009","article-title":"Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase","volume":"21","author":"Ramakrishnan","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ccr.2011.12.015_bib18","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1182\/blood-2007-09-110635","article-title":"Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells","volume":"111","author":"Saitoh","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.12.015_bib19","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.12.015_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ijc.24827","article-title":"Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma","volume":"126","author":"Schaefer","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccr.2011.12.015_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm2763","article-title":"Mechanisms of polycomb gene silencing: knowns and unknowns","volume":"10","author":"Simon","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccr.2011.12.015_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nrc1991","article-title":"Polycomb silencers control cell fate, development and cancer","volume":"6","author":"Sparmann","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2011.12.015_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement","volume":"4","author":"Su","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccr.2011.12.015_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","article-title":"Polycomb group protein ezh2 controls actin polymerization and cell signaling","volume":"121","author":"Su","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jcb.10729","article-title":"NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?","volume":"91","author":"Suh","year":"2004","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ccr.2011.12.015_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cytogfr.2010.06.002","article-title":"NF-\u03baB inducing kinase: a key regulator in the immune system and in cancer","volume":"21","author":"Thu","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ccr.2011.12.015_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nature08025","article-title":"The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs","volume":"459","author":"Trabucchi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2011.12.015_bib28","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","article-title":"A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis","volume":"137","author":"Valastyan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2011.12.015_bib30","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ccr.2011.12.015_bib31","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2011.12.015_bib32","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood-2004-09-3646","article-title":"Dual targeting of transformed and untransformed HTLV-1-infected T\u00a0cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia","volume":"106","author":"Watanabe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.12.015_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.micinf.2009.02.003","article-title":"Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription","volume":"11","author":"Yamagishi","year":"2009","journal-title":"Microbes Infect."},{"issue":"Suppl 2","key":"10.1016\/j.ccr.2011.12.015_bib34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03165123","article-title":"Human T lymphotropic virus type-I and adult T-cell leukemia in Japan","volume":"76","author":"Yamaguchi","year":"2002","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ccr.2011.12.015_bib35","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1158\/0008-5472.CAN-08-0769","article-title":"Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1","volume":"68","author":"Yeung","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.12.015_bib36","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ni.1676","article-title":"Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK","volume":"9","author":"Zarnegar","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccr.2011.12.015_bib37","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1073\/pnas.0707959105","article-title":"Control of canonical NF-kappaB activation through the NIK-IKK complex pathway","volume":"105","author":"Zarnegar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610811004776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610811004776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:54:55Z","timestamp":1761522895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610811004776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1535610811004776"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2011.12.015","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-\u03baB Pathway in Adult T Cell Leukemia and Other Cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2011.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}